FR2365588A1 - Procede de preparation d'androstanones-17 - Google Patents

Procede de preparation d'androstanones-17

Info

Publication number
FR2365588A1
FR2365588A1 FR7721932A FR7721932A FR2365588A1 FR 2365588 A1 FR2365588 A1 FR 2365588A1 FR 7721932 A FR7721932 A FR 7721932A FR 7721932 A FR7721932 A FR 7721932A FR 2365588 A1 FR2365588 A1 FR 2365588A1
Authority
FR
France
Prior art keywords
androstanone
formula
alkyl radical
androstanones
hydrogen atom
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7721932A
Other languages
English (en)
French (fr)
Other versions
FR2365588B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer Pharma AG
Original Assignee
Schering AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering AG filed Critical Schering AG
Publication of FR2365588A1 publication Critical patent/FR2365588A1/fr
Application granted granted Critical
Publication of FR2365588B1 publication Critical patent/FR2365588B1/fr
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P33/00—Preparation of steroids
    • C12P33/005—Degradation of the lateral chains at position 17
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0003—Androstane derivatives
    • C07J1/0011—Androstane derivatives substituted in position 17 by a keto group
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0003—Androstane derivatives
    • C07J1/0018—Androstane derivatives substituted in position 17 beta, not substituted in position 17 alfa
    • C07J1/0022—Androstane derivatives substituted in position 17 beta, not substituted in position 17 alfa the substituent being an OH group free esterified or etherified
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0003—Androstane derivatives
    • C07J1/0033—Androstane derivatives substituted in position 17 alfa and 17 beta
    • C07J1/0037—Androstane derivatives substituted in position 17 alfa and 17 beta the substituent in position 17 alfa being a saturated hydrocarbon group
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0003—Androstane derivatives
    • C07J1/0033—Androstane derivatives substituted in position 17 alfa and 17 beta
    • C07J1/004—Androstane derivatives substituted in position 17 alfa and 17 beta the substituent in position 17 alfa being an unsaturated hydrocarbon group
    • C07J1/0048—Alkynyl derivatives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J17/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, having an oxygen-containing hetero ring not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J9/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/822—Microorganisms using bacteria or actinomycetales
    • Y10S435/863—Mycobacterium

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Steroid Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
FR7721932A 1976-07-16 1977-07-18 Procede de preparation d'androstanones-17 Granted FR2365588A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19762632677 DE2632677A1 (de) 1976-07-16 1976-07-16 Verfahren zur herstellung von androstan-17-on-derivaten und deren verwendung

Publications (2)

Publication Number Publication Date
FR2365588A1 true FR2365588A1 (fr) 1978-04-21
FR2365588B1 FR2365588B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1982-06-25

Family

ID=5983514

Family Applications (4)

Application Number Title Priority Date Filing Date
FR7721932A Granted FR2365588A1 (fr) 1976-07-16 1977-07-18 Procede de preparation d'androstanones-17
FR7806455A Pending FR2372175A1 (fr) 1976-07-16 1978-03-07 Procede de preparation de l'hydroxy-3 androstanone-17 et de l'hydroxy-3 androstene-5 one-17
FR7806457A Pending FR2372176A1 (fr) 1976-07-16 1978-03-07 Procede de preparation de derives d'alcoxy-3 androstanones-17
FR7806456A Pending FR2372174A1 (fr) 1976-07-16 1978-03-07 Procede de preparation d'alcoxy-3 hydroxy-17 androstanes

Family Applications After (3)

Application Number Title Priority Date Filing Date
FR7806455A Pending FR2372175A1 (fr) 1976-07-16 1978-03-07 Procede de preparation de l'hydroxy-3 androstanone-17 et de l'hydroxy-3 androstene-5 one-17
FR7806457A Pending FR2372176A1 (fr) 1976-07-16 1978-03-07 Procede de preparation de derives d'alcoxy-3 androstanones-17
FR7806456A Pending FR2372174A1 (fr) 1976-07-16 1978-03-07 Procede de preparation d'alcoxy-3 hydroxy-17 androstanes

Country Status (18)

Country Link
US (1) US4179336A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
JP (1) JPS5315493A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AT (1) AT363196B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
BE (1) BE856860A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CH (3) CH627190A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CS (1) CS200517B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DD (4) DD137235A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DE (1) DE2632677A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DK (1) DK142372C (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
FR (4) FR2365588A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
GB (1) GB1585786A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
HU (4) HU182681B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
IE (1) IE45304B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
IT (1) IT1077339B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
NL (1) NL7706638A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
SE (1) SE440779B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
SU (1) SU980628A3 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
YU (1) YU164277A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS55148083A (en) * 1979-05-04 1980-11-18 Mitsubishi Chem Ind Ltd Microorganism
JPS55150893A (en) * 1979-05-11 1980-11-25 Mitsubishi Chem Ind Ltd Novel microorganism
JPS578794A (en) * 1980-06-17 1982-01-18 Mitsubishi Chem Ind Ltd Preparation of androstane-type steroid
US4755463A (en) * 1982-05-25 1988-07-05 Wisconsin Alumni Research Foundation Process for preparing steroids
US4444884A (en) * 1982-05-25 1984-04-24 Wisconsin Alumni Research Foundation Process for preparing steroids
DE69621281T2 (de) * 1995-02-28 2002-12-05 Nippon Shokubai Co., Ltd. Acryl-Säure-Derivate, Verfahren zur Herstellung von Acryl-Säure-Derivaten und Acryl-Säure-Polymere
LT2644206T (lt) * 2003-05-23 2019-05-27 Nektar Therapeutics Peg dariniai, susidedantys iš dviejų peg grandinių
EP2495242B1 (en) * 2009-10-29 2016-05-04 Industry-Academic Cooperation Foundation Yonsei University Novel vascular leak inhibitor
WO2012116290A2 (en) 2011-02-25 2012-08-30 Washington University Neuroactive 17(20)-z-vinylcyano-substituted steroids, prodrugs thereof, and methods of treatment using same
EP3572417A3 (en) 2011-10-14 2020-03-25 Sage Therapeutics, Inc. 3,3 disubstituted 19-nor pregnane compounds, compositions, and uses thereof
PT2935307T (pt) 2012-12-18 2018-07-31 Univ Washington Esteroides 19-alcoxi-17-substituídos neuroativos, úteis em métodos de tratamento
WO2014127201A1 (en) * 2013-02-15 2014-08-21 Washington University Neuroactive enantiomeric 15-, 16- and 17-substituted steroids as modulators for gaba type-a receptors
US9512170B2 (en) 2013-03-01 2016-12-06 Washington University Neuroactive 13, 17-substituted steroids as modulators for GABA type-A receptors
US9365502B2 (en) 2013-03-11 2016-06-14 Washington University Neuroactive substituted cyclopenta[b]phenanthrenes as modulators for GABA type-A receptors
US9562026B2 (en) 2013-03-14 2017-02-07 Washington University Neuroactive substituted cyclopent[a]anthracenes as modulators for GABA type-A receptors
WO2014169836A1 (en) 2013-04-17 2014-10-23 Sage Therapeutics, Inc. 19-nor neuroactive steroids and methods of use thereof
US9725481B2 (en) 2013-04-17 2017-08-08 Sage Therapeutics, Inc. 19-nor C3, 3-disubstituted C21-C-bound heteroaryl steroids and methods of use thereof
RS62312B1 (sr) 2013-04-17 2021-09-30 Sage Therapeutics Inc 19-nor c3,3-disupstituisani c21-n-pirazolil steroidi i postupci za njihovu upotrebu
CN117304245A (zh) 2013-04-17 2023-12-29 萨奇治疗股份有限公司 刺激神经活性的19-去甲类固醇及其使用方法
HUE053900T2 (hu) 2013-07-19 2021-07-28 Sage Therapeutics Inc Neuroaktív szteroidok, kompozíciók, és azok alkalmazásai
CN113750107B (zh) 2013-08-23 2025-02-11 萨奇治疗股份有限公司 神经活性类固醇、组合物和其用途
WO2015195962A1 (en) 2014-06-18 2015-12-23 Sage Therapeutics, Inc. Neuroactive steroids, compositions, and uses thereof
WO2016061537A1 (en) 2014-10-16 2016-04-21 Sage Therapeutics, Inc. Compositions and methods for treating cns disorders
AU2015331749A1 (en) 2014-10-16 2017-05-04 Sage Therapeutics, Inc. Compositions and methods for treating CNS disorders
WO2016082789A1 (en) 2014-11-27 2016-06-02 Sage Therapeutics, Inc. Compositions and methods for treating cns disorders
RS61530B1 (sr) 2015-01-26 2021-04-29 Sage Therapeutics Inc Kompozicije i postupci za lečenje poremećaja cns
US10329320B2 (en) 2015-02-20 2019-06-25 Sage Therapeutics, Inc. Neuroactive steroids, compositions, and uses thereof
AU2017297375B2 (en) 2016-07-11 2022-09-15 Sage Therapeutics, Inc. C17, C20, and C21 substituted neuroactive steroids and their methods of use
US20190233465A1 (en) 2016-07-11 2019-08-01 Sage Therapeutics, Inc. C7, c12, and c16 substituted neuroactive steroids and their methods of use
PH12021553005A1 (en) 2019-05-31 2023-08-14 Sage Therapeutics Inc Neuroactive steroids and compositions thereof

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2319650A1 (fr) * 1975-08-01 1977-02-25 Schering Ag Procede de preparation de derives de la 5-androstene-17-one et utilisation de ces substances

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3451892A (en) * 1965-10-19 1969-06-24 Schering Corp Process for the preparation of steroidal compounds
NL6705450A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) * 1965-10-22 1968-10-21
US3684657A (en) * 1970-05-11 1972-08-15 Searle & Co Selective microbiological degradation of steroidal 17-alkyls
US3759791A (en) * 1970-12-10 1973-09-18 Searle & Co Selective microbiological preparation of androst-4-ene-3,17-dione
US3738983A (en) * 1971-08-06 1973-06-12 Searle & Co Process for the preparation of 3-(3beta,17beta-dihydroxyandrost-5-en-17alpha-yl) propionic acid gamma-lactone

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2319650A1 (fr) * 1975-08-01 1977-02-25 Schering Ag Procede de preparation de derives de la 5-androstene-17-one et utilisation de ces substances

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
CA1976 *

Also Published As

Publication number Publication date
FR2372174A1 (fr) 1978-06-23
ATA504677A (de) 1980-12-15
FR2365588B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1982-06-25
CH629503A5 (de) 1982-04-30
AT363196B (de) 1981-07-10
DD132439A5 (de) 1978-09-27
HU182681B (en) 1984-02-28
DK142372C (da) 1981-03-23
FR2372175A1 (fr) 1978-06-23
CS200517B2 (en) 1980-09-15
NL7706638A (nl) 1978-01-18
DD136142A5 (de) 1979-06-20
DK142372B (da) 1980-10-20
SU980628A3 (ru) 1982-12-07
DK323677A (da) 1978-01-17
JPS6117477B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1986-05-07
SE7708192L (sv) 1978-01-17
SE440779B (sv) 1985-08-19
JPS5315493A (en) 1978-02-13
DE2632677C2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1988-06-16
IE45304L (en) 1978-01-16
IE45304B1 (en) 1982-07-28
DD136141A5 (de) 1979-06-20
CH627190A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1981-12-31
CH629222A5 (de) 1982-04-15
HU182790B (en) 1984-03-28
DE2632677A1 (de) 1978-01-26
YU164277A (en) 1982-08-31
GB1585786A (en) 1981-03-11
DD137235A5 (de) 1979-08-22
FR2372176A1 (fr) 1978-06-23
IT1077339B (it) 1985-05-04
HU182789B (en) 1984-03-28
BE856860A (fr) 1978-01-16
HU179344B (en) 1982-10-28
US4179336A (en) 1979-12-18

Similar Documents

Publication Publication Date Title
FR2365588A1 (fr) Procede de preparation d'androstanones-17
CA2164638A1 (fr) Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
TNSN86111A1 (fr) Procede de preparation d'hydroxyalkylxanthines tertiaires
FR2387658A1 (fr) Procede pour combattre les microorganismes
EP1245249A3 (fr) Utilisation d'un composé amphipathique cationique comme agent de transfection, comme adjuvant de vaccin, ou comme medicament
BE901224A (fr) Nouveaux derives d'indole utiles comme medicaments et intermediaires et procedes pour leur preparation.
FR2411179A1 (fr) Nouveaux derives de l'acide 2-(4-thio-2-oxoazetidine-1-yl)-3-methyl-crotonique et procedes pour leur preparation
JPH0641412B2 (ja) プロリンヒドロキシラーゼおよびリジンヒドロキシラーゼ抑制のための薬剤
BE904945A (fr) Nouveaux derives du thiazole, leur preparation et leur utilisation en therapeutique.
FR2426694A1 (fr) Cephalosporines perfectionnees, leur procede de preparation et leur application therapeutique
CA2023645A1 (fr) Procede pour la preparation enantioselective de derives de la phenylisoserine
BE904757A (fr) Esters gras bi-ou tri-eniques d'erythromycine a, leur procede de preparation et compositons pharmaceutiques et cosmetiques les contenant.
FR2401913A1 (fr) Nouveaux 3-(2-hydroxy-4(substituant)-phenyl)-azacycloalcanes et medicament les contenant
KR900016098A (ko) 카페인산의 유도체 및 이를 함유하는 약제학적 조성물
KR860008973A (ko) 2-피롤리돈 유도체
CA2326710A1 (fr) Nouveaux derives de dihydrofuro-¬3,4-b|quinolein-1-ones, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
BE904641A (fr) 5-pyrimidine-carboxamides et traitement de la leucemie et des tumeurs avec ces derniers.
CA2289599A1 (fr) Composes heterocycliques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
FR2397425A1 (fr) Nouveaux derives de la daunorubicine, leur preparation et les compositions qui les contiennent
BE904983A (fr) Acides propenylaminothiazolylcephalosporaniques 3-substitues et leurs esters.
FR2402011A1 (fr) Procede de preparation de p-benzoquinone-diacetals par oxydation anodique du benzene ou d'un alcoxy-benzene en presence de methanol
AU5157679A (en) Isatin derivatives
BE901278A (fr) Derives de 4,5,6,7-tetrahydrothiazolo [5,4-c] pyridine, procedes pour les preparer et medicament les contenant.
BE905654A (fr) Derives de la armstrong 2-1,2,4-triazoline-5-one, procede pour leur preparation et leurs utilisations.
BE1000719A4 (fr) Derives de 3-(hydroxymethyl)-isoquinoleine, procede pour les preparer et compositions pharmaceutiques les contenant.

Legal Events

Date Code Title Description
ST Notification of lapse